4th International Conference on Neurology and Brain Disorders

September 09-11, 2021

September 09 -11, 2021 | Virtual Event

INBC 2021

Speaker at Neurology and Brain Disorders 2021 - Ken Ware
Keynote Presentation
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

An initial study involving a random selection of 5 patients who were diagnosed MND positive and who were in at a moderately advanced stage (e.g. not able to walk unassisted, voice impedance and moderate upper limb and discriminative fine motor impairments), was implemented initia [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Radu Mutihac
Keynote Presentation
Radu Mutihac, University of Bucharest, Romania

Although the diagnosis of neurological disorders still depends on clinical criteria, recent advances in neuroimaging techniques, such as magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), diffusion tensor imag [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Marat Akhmet
Keynote Presentation
Marat Akhmet, Middle East Technical University, Turkey

The comprehension of the world through fractals promises to be one of the effective ways for creative scientific, biological, social, medical, and industrial activities. We are confident that self-similarity extended to arbitrary small scales of real world subjects is in the core [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Li Min Chen
Oral Presentation
Li Min Chen, Vanderbilt University Medical Center, United States

SCI has devastating consequences for patients with severe impairments of motor and/or sensory functions, and has a significant impact on quality of life, life expectancy and economic burden. There are no fully restorative therapies for SCI as yet, but preclinical studies have fou [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Alberto Negro
Oral Presentation
Alberto Negro, University of Campania Luigi Vanvitelli, Italy

The relationship between psychosocial stress at work and mental health outcome is well-known. Brain-imaging studies hypothesize morphological brain modifications connected to work-related stress.To our knowledge this is the first study describing the link between work c haracteri [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Oleg.L Serov
Oral Presentation
Oleg.L Serov, Russian Academy of Sciences, Russian Federation

Copy number variations (CNVs) of the 3p26.3 region are often the cause of neurodevelopmental disorders, including intellectual disability, developmental delay and autism spectrum disorder. Recently, a publication appeared with description a patient-carrier of a duplication involv [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Jeff Erichsen
Oral Presentation
Jeff Erichsen, NeuroPhysics Therapy Rehabilitation, Australia

The distribution of emitted thermal energy and more predominately calculated temperatures from the skin have long been explored as a method in determining symmetry, balance and health in the human system; or lack thereof. In recent years, the Infrared Thermography (IRT) camera ha [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Maria Gridina
Oral Presentation
Maria Gridina, Institute of Cytology and Genetics SB RAS, Russian Federation

Copy number variations (CNVs) of the 3p26.3 region are often the cause of neurodevelopmental disorders, including intellectual disability, developmental delay and autism spectrum disorder. Recently, a publication appeared with description a patient-carrier of a duplication involv [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Jia-Tang Zhang
Oral Presentation
Jia-Tang Zhang, Department of Neurology, China

Background Sporadic Creutzfeldt-Jakob disease (sCJD) is an extremely rare fatal and infectious neurodegenerative brain disorder characterized by rapidly progressive dementia, cerebellar ataxia and visual disturbance. This study summarized 104 sCJD cases in the First Medical Cent [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Deanna Anderlini
Oral Presentation
Deanna Anderlini, The University of Queensland, Australia

Introduction Data from UK and USA’ studies show that the average age of stroke patients is falling. Give that stroke is the main cause of adult disability, it becomes essential for policy makers to know the trends and the outcomes of the prevention campaigns/therapies.  [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Shaun Gruenbaum
Oral Presentation
Shaun Gruenbaum, Mayo Clinic, United States

Epilepsy is a heterogeneous group of chronic neurological disorders characterized by recurrent, spontaneous seizures. Epilepsy affects approximately 1% of the population worldwide and carries a significant societal burden. The treatment of epilepsy is focused on reducing the freq [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Anna Litwiniuk
Poster Presentation
Anna Litwiniuk, Centre of Postgraduate Medical Education, Poland

Alzheimer's disease (AD) is believed to contribute to 60–70% of neurodegenerative dementia cases. The pathogenesis of AD is associated with increased oxidative stress and inflammatory response. Neurons are particularly sensitive to oxidative disturbances caused by incre [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Svyatoslav Medvedev
Keynote Presentation
Svyatoslav Medvedev, Institute of the Human Brain RAS, Russian Federation

Importance of physiological researches of the altered states of consciousness (ASC) arising at adaptation of the person to performance of a certain activity is known (for example illusions of monototy in pilots, cosmonauts, operators of complex systems). This importance follows a [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Melnyk Nataliia O
Keynote Presentation
Melnyk Nataliia O, Bogomolets National Medical University, Ukraine

The experiments established a number of patterns in the development of demyelinating and degenerative changes in the brain, spinal cord and sciatic nerve in the acute and long term after stroke. An experimental model of unilateral hemorrhagic stroke, characterized by 100% hematom [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Salim Hirani
Oral Presentation
Salim Hirani, Ysbyty Gwynedd Hospital, United Kingdom

The severity of carpal tunnel syndrome (CTS) may be categorised in a number of ways utilising one of a range of presently available grading tools. The grading systems proposed by Bland and Padua are the most commonly used, however, both have limitations, which are discussed in de [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Sven-Erik Eriksson
Oral Presentation
Sven-Erik Eriksson, Division of Neurology, Sweden

This study is about reporting annual events of strokes, myocardial infarctions and deaths, in patients who had been hospitalized due to TIA/stroke in 1986 and followed up until February 2011; with or without cancer, and in patients with assessed lipid values after admission also [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Mohamed Ben Amar
Oral Presentation
Mohamed Ben Amar, University of Montreal, Canada

In order to assess the current therapeutic potential of cannabis and cannabinoids in brain diseases, a meta-analysis was performed through Medline and PubMed up to September 1, 2019.The key words used were cannabis, marijuana, marihuana, hashish, hashich, cannabinoids, tetrahydro [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Stewart Cheffirs
Oral Presentation
Stewart Cheffirs, Ken Ware’s NeuroPhysics Therapy, Australia

15-year-old patient presented with long term chronic migraines. Pre NeuroPhysics Therapy (NPT) the patient spent just 10 days at school throughout the year due to the severity of the migraines. The medical approach was to attempt to manage the symptoms/condition through long term [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Alberto A. Rasia-Filho
Oral Presentation
Alberto A. Rasia-Filho, Federal University of Health Sciences of Porto Alegre, Brazil

The visualization of nerve cells is important for the advancement of neurological research and the comprehension of the foundations of the functioning of the human brain. At the cellular level, dendritic spines are the smallest multifunctional units that reflect cellular connecti [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Minee L. Choi
Oral Presentation
Minee L. Choi, UCL Institute of Neurology, United Kingdom

Misfolding and aggregation of proteins such as amyloid-β (Aβ), tau and alpha-synuclein (?-syn) is the predominant pathology underlying the neurodegenerative disorders, Alzheimer’s disease (AD) and Parkinson’s disease (PD). Although end stage insoluble produc [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Dubois Jeremy
Oral Presentation
Dubois Jeremy, National Institute of Health and Medical Research, France

Care course improves interprofessional coordination, care quality and decreases costs. Système National des Données de Santé (SNDS), a medical administrative big data base, allows us to rebuild and study care course for hospital care and home care. We will ta [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Julia Boytsova
Oral Presentation
Julia Boytsova, Researcher in Laboratory of Neuro visualisation, Russian Federation

Over the past 10-15 years, a huge amount of works on the study of meditation has been accumulated. A number of scientists acknowledge that voluntary control of attention plays a key role in meditation practices. And this "high-level" voluntary attention processes during [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Balakrishnan Arivalagan
Oral Presentation
Balakrishnan Arivalagan, Command Hospital Air Force , India

21 yr male presented with no co morbidities presented with witnessed seizure(seminology characterized by jerky movements of left angle of mouth and left upper limb with up rolling eyeball and tongue bite followed by post ictal confusion).Managed conservatively by antiepileptic, a [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Maria Joao Cabral Sacadura,
Poster Presentation
Maria Joao Cabral Sacadura,, Catholic University of Portugal and University of Coimbra, Portugal

The End-Stage Renal Disease (ESRD) is a worldwide public health problem. For about 70 years, the scientific community has been aware of and has focused on the study of kidney function deficiencies and cognitive decline. There is empirical evidence that ESRD is associated with var [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Kapil Kumar Avasthi
Poster Presentation
Kapil Kumar Avasthi, Dept. of Medical Genetics, India

Introduction  Congenital myopathies are heterogeneous group of neuromuscular disorders and characterised by hypotonia early onset muscular weakness, developmental delay. Congenital myopathies are classified into centranuclear myopathies, nemaline myopathies, core myopathies [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Sean Ing Loon Chua
Poster Presentation
Sean Ing Loon Chua, Duke-NUS Medical School, Singapore

Background: The prevalence of dementia, which presents as cognitive decline in one or more cognitive domains affecting function, is increasing worldwide. Traditional cognitive screening tools for dementia have their limitations, with emphasis on memory and, to a lesser extent, on [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Maira Balgayeva
Poster Presentation
Maira Balgayeva, National Children's Rehabilitation Center, Kazakhstan

Aim:. The problem of medical rehabilitation and social adaptation of children with organic diseases of a nervous system, first, with the cerebral palsy (CP), remains relevant. The considerable prevalence, complexity and versatility of clinical manifestations, severity and high pe [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Genica Lynne Maylem
Poster Presentation
Genica Lynne Maylem, Institute of Personalized and Molecular Medicine at The Medical City, Philippines

Background Neurologic disorders are caused by a either neural cell loss or neurologic cell injury processes. Management of these disorders would therefore be to replace the lost cells, clear the pathological hallmarks or repair cell function. Stem cells offer the possibility of [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Akbarbek Vakhobov Anorbekovich
Poster Presentation
Akbarbek Vakhobov Anorbekovich, The Tashkent Medical Academy,

Sensorineural hearing loss is an urgent problem, it significantly reduces the quality of life of patients, the molecular mechanisms of its occurrence are not fully understood, and in fact there are no effective and safe methods of treatment that stop the progression of the proces [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Amritha M.L
Poster Presentation
Amritha M.L, National Institute of Speech and Hearing (NISH), India

Lymphangiomatous lesions are rare congenital malformations of the lymphatic system that occur throughout the body with greater frequency in the cervico facial area. The incidence of lymphangiomas has been reported to range from 1.2 to 2.8 per 1000 newborns. The most prominent sig [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Guy Massicotte
Poster Presentation
Guy Massicotte, Trois-Rivières University, Canada

Tau proteins help maintaining the structure of a neuron, including tiny tube-like structures called microtubules, which deliver nutrients throughout cells. However, when hyperphosphorylated, these proteins can become toxic for neurons by forming tangles in the hippocampus; one im [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - K. Bhuvaneswari
Poster Presentation
K. Bhuvaneswari, Bharathidasan University, India

Introduction Motor neuron disease (MND) refers to a heterogeneous group of conditions characterized by degeneration. Lower Motor Neurons (those that have a cell bodies in the cranial nerve nuclei or in the anterior horn of the spinal cord and synapse directly on muscle)andUpper [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Nikhila A
Poster Presentation
Nikhila A, Holy Cross College, India

Mild cognitive impairment (MCI) is the transitional stage between normal aging and Alzheimer’s disease.The criteria for mild cognitive impairment for person with memory loss but without dementia given by Petersen et al., 1991 were memory issue, abnormal memory for age, gene [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Roberto Menicagli
Poster Presentation
Roberto Menicagli, University of Pavia, Italy

Alzheimer's disease (AD) is a neurodegenerative disease characterized by a progressive loss of neurons.. Recent studies indicate that before the AD ,emerges a process of hypometabolism with a simultaneous reduction of the autophagy  ;this  fact promotes the  in [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Mohamad Ayajuddin
Poster Presentation
Mohamad Ayajuddin, Nagaland University, India

Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting approximately 1% of the population over age 50. Exposure to environmental toxins has been found to be a risk factor for sporadic PD. Herbicide rotenone has been shown to cause Parkinsoni [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Yahia Al Turk
Poster Presentation
Yahia Al Turk, Henry Ford Hospital, United States

Behçet disease was first described in 1924 by a Turkish dermatologist, Dr. Hulusi Behçet. Oral and skin lesions are present in >75% of patients, and genital lesions are the most specific manifestation, and neurologic disease occurs in less than 10% of patients wi [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Roberto Di Maio
Keynote Presentation
Roberto Di Maio, University of Pittsburgh, United States

Oxidative stress has been described as a major cause of nigrostriatal degeneration in familial and idiopathic Parkinson’s disease (PD). Moreover, NADPH oxidase 2 (NOX2) and the mitochondrial electron transport chain, the major enzymatic sources of reactive oxygen species (R [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Yuri Danilov
Keynote Presentation
Yuri Danilov, Rehaline Rehabilitation Center, Russian Federation

Translingual neurostimulation (TLNS) and new neurorehabilitation technology represent a synthesis of a non-invasive brain stimulation technique with multiple applications in physical medicine, cognitive, and affective neurosciences. Our new stimulation method appears promising fo [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Federico Licastro
Keynote Presentation
Federico Licastro, School of Medicine, Italy

Ageing is associated with declining immune responses and Alzheimer’s disease (AD). Infective agents, both bacteria and viruses, have been suggested to play a role in the clinical progression of AD. Decreased immune efficiency viruses might increase the brain risk of chronic [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Pian Wang
Oral Presentation
Pian Wang, Chengdu Fifth Peoples’ Hospital, China

The proportion of cognitive dysfunction occurring three months after stroke has been estimated between 24% and 39%. Post-stroke cognitive impairment (PSCI) seriously reduces patients’ quality of life. The active control of hyperglycemia and hyperlipidemia is recommended for [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Fernanda Bonilla Colomé
Oral Presentation
Fernanda Bonilla Colomé, Pediatric Neurologist, Brazil

Spinal muscular atrophies (SMA), prevalence of 1.5:100.000, recessive inheritance, neuromuscular diseases with anterior medullary horn degeneration, are caused by mutations in the survival of motor neuron protein, represented by SMN1 and SMN2 genes, supporting the motor neurons i [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Wen-Chang Li
Oral Presentation
Wen-Chang Li, School of Psychology and Neuroscience, United Kingdom

Most vertebrates show concussion responses when their heads are hit suddenly by heavy objects.  Previous studies have focused on the direct physical injuries to the neural tissue caused by the concussive blow.  We study a similar behaviour in a simple vertebrate, the Xe [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Meenal Dhall
Oral Presentation
Meenal Dhall, University of Delhi, India

Quality of Life (QOL) is a broad multidimensional conception that includes subjective evaluations of both positive and negative aspects of life. Although health is one of the important domains of overall quality of life, there are other domains as well- like jobs, housing, school [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Raafat Abdeldayem
Oral Presentation
Raafat Abdeldayem, Mansoura University, Egypt

Background: Seizures often occur in substance abusers. The present work aimed to study the etiology of non-response to antiepileptic drugs by estimating their serum levels and screening of drugs and substance abuse in patients with resistant epilepsy. Methods: this study [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Juan Carlos Mario Andreani
Oral Presentation
Juan Carlos Mario Andreani, Director of the Provincial Program of Neuromodulation – Pcia Buenos Aires, Argentina

Refractory Spasticity is a harmful and disabling condition, caused by upper motor lesions of different aetiologies, producing with time motor dysfunction, skeletal deformities, muscle atrophy, etc, which has poor options of treatment hence basic and clinical research is being con [....] » Read More

Speaker at Neurology and Brain Disorders 2021 - Doaa Ali Abdelmonsif
Oral Presentation
Doaa Ali Abdelmonsif, University of Alexandria, Egypt

Multiple sclerosis is among the most common causes of neurological disabilities in young adults. Over the past decade, several therapeutic strategies have emerged as having potential neuroprotective and neuroregenerative properties. We investigated the effect of intranasal admini [....] » Read More

Watsapp